IBDEI1I7 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24321,1,4,0)
 ;;=4^I13.2
 ;;^UTILITY(U,$J,358.3,24321,2)
 ;;=^5007070
 ;;^UTILITY(U,$J,358.3,24322,0)
 ;;=I15.0^^82^1052^15
 ;;^UTILITY(U,$J,358.3,24322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24322,1,3,0)
 ;;=3^Renovascular Hypertension
 ;;^UTILITY(U,$J,358.3,24322,1,4,0)
 ;;=4^I15.0
 ;;^UTILITY(U,$J,358.3,24322,2)
 ;;=^5007071
 ;;^UTILITY(U,$J,358.3,24323,0)
 ;;=I15.1^^82^1052^3
 ;;^UTILITY(U,$J,358.3,24323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24323,1,3,0)
 ;;=3^Hypertension Secondary to Oth Renal Disorders
 ;;^UTILITY(U,$J,358.3,24323,1,4,0)
 ;;=4^I15.1
 ;;^UTILITY(U,$J,358.3,24323,2)
 ;;=^5007072
 ;;^UTILITY(U,$J,358.3,24324,0)
 ;;=I15.2^^82^1052^2
 ;;^UTILITY(U,$J,358.3,24324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24324,1,3,0)
 ;;=3^Hypertension Secondary to Endocrine Disorders
 ;;^UTILITY(U,$J,358.3,24324,1,4,0)
 ;;=4^I15.2
 ;;^UTILITY(U,$J,358.3,24324,2)
 ;;=^5007073
 ;;^UTILITY(U,$J,358.3,24325,0)
 ;;=I15.8^^82^1052^16
 ;;^UTILITY(U,$J,358.3,24325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24325,1,3,0)
 ;;=3^Secondary Hypertension,Oth
 ;;^UTILITY(U,$J,358.3,24325,1,4,0)
 ;;=4^I15.8
 ;;^UTILITY(U,$J,358.3,24325,2)
 ;;=^5007074
 ;;^UTILITY(U,$J,358.3,24326,0)
 ;;=I15.9^^82^1052^17
 ;;^UTILITY(U,$J,358.3,24326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24326,1,3,0)
 ;;=3^Secondary Hypertension,Unspec
 ;;^UTILITY(U,$J,358.3,24326,1,4,0)
 ;;=4^I15.9
 ;;^UTILITY(U,$J,358.3,24326,2)
 ;;=^5007075
 ;;^UTILITY(U,$J,358.3,24327,0)
 ;;=I16.0^^82^1052^14
 ;;^UTILITY(U,$J,358.3,24327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24327,1,3,0)
 ;;=3^Hypertensive Urgency
 ;;^UTILITY(U,$J,358.3,24327,1,4,0)
 ;;=4^I16.0
 ;;^UTILITY(U,$J,358.3,24327,2)
 ;;=^8133013
 ;;^UTILITY(U,$J,358.3,24328,0)
 ;;=I16.1^^82^1052^7
 ;;^UTILITY(U,$J,358.3,24328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24328,1,3,0)
 ;;=3^Hypertensive Emergency
 ;;^UTILITY(U,$J,358.3,24328,1,4,0)
 ;;=4^I16.1
 ;;^UTILITY(U,$J,358.3,24328,2)
 ;;=^8204721
 ;;^UTILITY(U,$J,358.3,24329,0)
 ;;=I16.9^^82^1052^6
 ;;^UTILITY(U,$J,358.3,24329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24329,1,3,0)
 ;;=3^Hypertensive Crisis,Unspec
 ;;^UTILITY(U,$J,358.3,24329,1,4,0)
 ;;=4^I16.9
 ;;^UTILITY(U,$J,358.3,24329,2)
 ;;=^5138600
 ;;^UTILITY(U,$J,358.3,24330,0)
 ;;=A07.0^^82^1053^5
 ;;^UTILITY(U,$J,358.3,24330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24330,1,3,0)
 ;;=3^Balantidiasis
 ;;^UTILITY(U,$J,358.3,24330,1,4,0)
 ;;=4^A07.0
 ;;^UTILITY(U,$J,358.3,24330,2)
 ;;=^12533
 ;;^UTILITY(U,$J,358.3,24331,0)
 ;;=A07.1^^82^1053^9
 ;;^UTILITY(U,$J,358.3,24331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24331,1,3,0)
 ;;=3^Giardiasis [lambliasis]
 ;;^UTILITY(U,$J,358.3,24331,1,4,0)
 ;;=4^A07.1
 ;;^UTILITY(U,$J,358.3,24331,2)
 ;;=^5000049
 ;;^UTILITY(U,$J,358.3,24332,0)
 ;;=A07.2^^82^1053^7
 ;;^UTILITY(U,$J,358.3,24332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24332,1,3,0)
 ;;=3^Cryptosporidiosis
 ;;^UTILITY(U,$J,358.3,24332,1,4,0)
 ;;=4^A07.2
 ;;^UTILITY(U,$J,358.3,24332,2)
 ;;=^29629
 ;;^UTILITY(U,$J,358.3,24333,0)
 ;;=A07.3^^82^1053^12
 ;;^UTILITY(U,$J,358.3,24333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24333,1,3,0)
 ;;=3^Isosporiasis
 ;;^UTILITY(U,$J,358.3,24333,1,4,0)
 ;;=4^A07.3
 ;;^UTILITY(U,$J,358.3,24333,2)
 ;;=^5000050
 ;;^UTILITY(U,$J,358.3,24334,0)
 ;;=A07.4^^82^1053^8
 ;;^UTILITY(U,$J,358.3,24334,1,0)
 ;;=^358.31IA^4^2
